查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888694

經導管心臟瓣膜市場規模、佔有率和趨勢分析報告：按應用、技術、地區和細分市場預測（2025-2033 年）

Transcatheter Heart Valve Market Size, Share & Trends Analysis Report By Application, By Technology, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

經導管心臟瓣膜市場摘要

2024年全球經導管心臟瓣膜市場規模估計為54.9億美元，預計到2033年將達到212.4億美元。

預計 2025 年至 2033 年的複合年成長率將達到 16.49%。瓣膜性心臟病的盛行率不斷上升，尤其是在老化社會中，這推動了對經導管心臟瓣膜 (THV) 治療的需求，包括經導管主動脈瓣置換術術 (TAVR)，用於治療主動脈瓣狹窄和二尖瓣逆流等疾病。

推動經導管心臟瓣膜產業發展的關鍵因素包括經導管心臟瓣膜設計的不斷改進、影像技術和輸送系統的進步，以及人們對微創手術日益成長的偏好。與傳統的開胸手術相比，微創手術有望帶來更快的恢復時間、更少的併發症和更低的醫療成本。

2024年9月，美國疾病管制與預防中心（CDC）報告稱，75%的美國美國對瓣膜性心臟病的了解有限。這種認知不足對高風險族群的影響尤其顯著，包括65歲以上的老年人。在美國，每年有超過500萬人被診斷出患有瓣膜性心臟病，該疾病每年導致超過2.5萬人死亡。

心臟瓣膜疾病的盛行率不斷上升，尤其是在老化人口中，是經導管心臟瓣膜置換術（THV）需求的主要促進因素。隨著主動脈瓣狹窄和二尖瓣逆流等疾病的日益常見，對THV等先進治療方案的需求也日益成長。 2024年9月，美國疾病管制與預防中心（CDC）報告稱，75%的美國成年人對心臟瓣膜疾病的了解有限。這種認知不足的情況在高風險族群中尤為突出，例如65歲及以上的老年人。在美國，每年有超過500萬人被診斷出患有心臟瓣膜疾病，超過2.5萬人死於該疾病。

經導管主動脈瓣膜（THV）設計的持續改進，特別是瓣膜耐久性的提升、植入操作的簡單性以及患者預後的改善，是推動THV發展的關鍵因素。影像技術的進步和瓣膜輸送系統的改進也顯著提高了手術成功率，並擴大了THV手術的適用患者群體。 2024年8月，波士頓科學公司宣布其ACURATE Prime主動脈瓣膜系統獲得CE認證。這款先進的經導管主動脈瓣膜置換系統採用新型瓣膜尺寸，以適應體型較大的患者，適用於低危險群、中度風險和高風險重度主動脈瓣狹窄患者。該系統採用自膨脹式設計和改進的釋放機制，提高了瓣膜定位的精準度，從而改善患者的整體預後。

目錄

第1章調查方法和範圍

第2章執行摘要

3. 經導管心臟瓣膜市場變數、趨勢和範圍

  • 市場譜系展望
    • 母市場展望
    • 相關及輔助市場展望
  • 市場動態
  • 經導管心臟瓣膜市場分析工具
    • 產業分析 - 波特五力
    • PESTEL 分析

第4章 經導管心臟瓣膜市場：按應用分類的估算和趨勢分析

  • 定義和範圍
  • 按應用領域分類的市場佔有率分析（2024 年和 2033 年）
  • 經導管主動脈瓣膜
  • 經導管肺動脈瓣膜
  • 經導管二尖瓣

第5章 經導管心臟瓣膜市場：依技術分類的估算與趨勢分析

  • 定義和範圍
  • 按應用領域分類的市場佔有率分析（2024 年和 2033 年）
  • 球囊擴張型經導管瓣膜
  • 自膨式經導管瓣膜

第6章 經導管心臟瓣膜市場：區域估算與趨勢分析

  • 區域儀錶板
  • 市場規模、預測與趨勢分析（2021-2033）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭情勢

  • 公司/競爭對手分類
  • 供應商概況
    • 主要企業市佔率分析，2024 年
    • Medtronic
    • Abbott
    • Braile Biomedica
    • Meril Life Sciences Pvt. Ltd., Inc.
    • Edwards Lifesciences Corporation
    • MicroPort Scientific Corporation
    • Venus Medtech（Hangzhou）Inc.
    • JenaValve
    • Biosensors International Group, Ltd
    • HLT Medical（Bracco）
Product Code: GVR-1-68038-096-5

Transcatheter Heart Valve Market Summary

The global transcatheter heart valve market size was estimated at USD 5.49 billion in 2024 and projected to reach USD 21.24 billion by 2033, growing at a CAGR of 16.49% from 2025 to 2033. The rising prevalence of heart valve diseases, particularly in the aging population, is driving the demand for transcatheter heart valve (THV) procedures, such as TAVR, especially for conditions such as aortic stenosis and mitral regurgitation.

Key factors propelling the growth of the transcatheter heart valve industry include continuous improvements in THV design, advancements in imaging and delivery systems, and the increasing preference for minimally invasive surgeries, which offer shorter recovery times, reduced complications, and lower healthcare costs compared to traditional open-heart surgery.

In September 2024, the CDC reported that 75% of adults in the U.S. have limited knowledge about heart valve disease. This lack of awareness extends to high-risk groups, particularly individuals aged 65 and older. Each year, over 5 million people in the U.S. receive a diagnosis of heart valve disease, contributing to more than 25,000 fatalities attributed to this condition annually.

The growing prevalence of heart valve diseases, particularly in the aging population, significantly drives the demand for transcatheter heart valve (THV) procedures. Conditions such as aortic stenosis and mitral regurgitation are becoming more common, necessitating advanced treatment solutions such as THVs. In September 2024, the CDC reported that 75% of adults in the U.S. have limited knowledge about heart valve disease. This lack of awareness extends to high-risk groups, particularly individuals aged 65 and older. Each year, over 5 million people in the U.S. receive a diagnosis of heart valve disease, contributing to more than 25,000 fatalities attributed to this condition annually.

Continuous improvements in THV design, including enhanced valve durability, ease of implantation, and improved patient outcomes, are crucial drivers. Advancements in imaging techniques and valve delivery systems have also significantly improved procedural success and expanded the patient pool eligible for THV procedures. In August 2024, Boston Scientific announced that its ACURATE Prime Aortic Valve System has received CE mark approval. This state-of-the-art transcatheter aortic valve replacement system features a new valve size to serve patients with larger anatomies and is indicated for individuals at low, intermediate, and high risk experiencing severe aortic stenosis. The system features a self-expanding design and a refined deployment mechanism, enhancing the accuracy of valve positioning to improve overall patient outcomes.

Global Transcatheter Heart Valve Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global transcatheter heart valve market report based on application, technology, and region:

  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Transcatheter Aortic Valve
  • Transcatheter Pulmonary Valve
  • Transcatheter Mitral Valve
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Balloon Expanded Transcatheter Valve
  • Self-Expanded Transcatheter Valve
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Technology
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Transcatheter Heart Valve Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of valvular heart diseases and aging population
      • 3.2.1.2. Increasing preference for minimally invasive cardiac procedures
      • 3.2.1.3. Technological advancements in valve design and delivery systems
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High procedural and device costs limiting accessibility
      • 3.2.2.2. Complications related to valve durability and thrombosis risk
    • 3.2.3. Market developments
      • 3.2.3.1. Key clinical trials in the transcatheter heart valve market, by region
      • 3.2.3.2. Recent product launches in the transcatheter heart valve market, by region
      • 3.2.3.3. Emerging products in the transcatheter heart valve market, by region
    • 3.2.4. Competitive factors and strategies
      • 3.2.4.1. Clinical insights
      • 3.2.4.2. Emerging technologies
      • 3.2.4.3. Market appeal
      • 3.2.4.4. Physician training and marketing
      • 3.2.4.5. Product improvements and innovations
      • 3.2.4.6. Mergers, acquisitions, and partnerships
      • 3.2.4.7. Product portfolio management
  • 3.3. Transcatheter Heart Valve Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Transcatheter Heart Valve Market: Application Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Application Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Transcatheter Aortic Valve
    • 4.4.1. Transcatheter aortic valve market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Transcatheter Pulmonary Valve
    • 4.5.1. Transcatheter pulmonary valve market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Transcatheter Mitral Valve
    • 4.6.1. Transcatheter mitral valve market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Transcatheter Heart Valve Market: Technology Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Application Market Share Analysis, 2024 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Balloon Expanded Transcatheter Valve
    • 5.4.1. Balloon expanded transcatheter valve market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Self-Expanded Transcatheter Valve
    • 5.5.1. Self-expanded transcatheter valve market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Transcatheter Heart Valve Market: Regional Estimates & Trend Analysis by Application and Technology

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Vendor Landscape
    • 7.2.1. Key company market share analysis, 2024
    • 7.2.2. Medtronic
      • 7.2.2.1. Overview
      • 7.2.2.2. Financial Performance
      • 7.2.2.3. Product Benchmarking
      • 7.2.2.4. Strategic Initiatives
    • 7.2.3. Abbott
      • 7.2.3.1. Overview
      • 7.2.3.2. Financial Performance
      • 7.2.3.3. Product Benchmarking
      • 7.2.3.4. Strategic Initiatives
    • 7.2.4. Braile Biomedica
      • 7.2.4.1. Overview
      • 7.2.4.2. Financial Performance
      • 7.2.4.3. Product Benchmarking
      • 7.2.4.4. Strategic Initiatives
    • 7.2.5. Meril Life Sciences Pvt. Ltd., Inc.
      • 7.2.5.1. Overview
      • 7.2.5.2. Financial Performance
      • 7.2.5.3. Product Benchmarking
      • 7.2.5.4. Strategic Initiatives
    • 7.2.6. Edwards Lifesciences Corporation
      • 7.2.6.1. Overview
      • 7.2.6.2. Financial Performance
      • 7.2.6.3. Product Benchmarking
      • 7.2.6.4. Strategic Initiatives
    • 7.2.7. MicroPort Scientific Corporation
      • 7.2.7.1. Overview
      • 7.2.7.2. Financial Performance
      • 7.2.7.3. Product Benchmarking
      • 7.2.7.4. Strategic Initiatives
    • 7.2.8. Venus Medtech (Hangzhou) Inc.
      • 7.2.8.1. Overview
      • 7.2.8.2. Financial Performance
      • 7.2.8.3. Product Benchmarking
      • 7.2.8.4. Strategic Initiatives
    • 7.2.9. JenaValve
      • 7.2.9.1. Overview
      • 7.2.9.2. Financial Performance
      • 7.2.9.3. Product Benchmarking
      • 7.2.9.4. Strategic Initiatives
    • 7.2.10. Biosensors International Group, Ltd
      • 7.2.10.1. Overview
      • 7.2.10.2. Financial Performance
      • 7.2.10.3. Product Benchmarking
      • 7.2.10.4. Strategic Initiatives
    • 7.2.11. HLT Medical (Bracco)
      • 7.2.11.1. Overview
      • 7.2.11.2. Financial Performance
      • 7.2.11.3. Product Benchmarking
      • 7.2.11.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America transcatheter heart valve market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 4 North America transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 5 U.S. transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 6 U.S. transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 7 Canada transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 8 Canada transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 9 Mexico transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 10 Mexico transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 11 Europe transcatheter heart valve market, by region, 2021 - 2033 (USD Million)
  • Table 12 Europe transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 13 Europe transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 14 Germany transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 15 Germany transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 16 UK transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 17 UK transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 18 France transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 19 France transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 20 Italy transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 21 Italy transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 22 Spain transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 23 Spain transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 24 Denmark transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 25 Denmark transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 26 Sweden transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 27 Sweden transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 28 Norway transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 29 Norway transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific transcatheter heart valve market, by region, 2021 - 2033 (USD Million)
  • Table 31 Asia Pacific transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 32 Asia Pacific transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 33 China transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 34 China transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 35 Japan transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 36 Japan transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 37 India transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 38 India transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 39 South Korea transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 40 South Korea transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 41 Australia transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 42 Australia transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 43 Thailand transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 44 Thailand transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 45 Latin America transcatheter heart valve market, by region, 2021 - 2033 (USD Million)
  • Table 46 Latin America transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 47 Latin America transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 48 Brazil transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 49 Brazil transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 50 Argentina transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 51 Argentina transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 52 MEA transcatheter heart valve market, by region, 2021 - 2033 (USD Million)
  • Table 53 MEA transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 54 MEA transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 55 South Africa transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 56 South Africa transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 57 Saudi Arabia transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 58 Saudi Arabia transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 59 UAE transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 60 UAE transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)
  • Table 61 Kuwait transcatheter heart valve market, by application, 2021 - 2033 (USD Million)
  • Table 62 Kuwait transcatheter heart valve market, by technology, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Transcatheter heart valve market: outlook
  • Fig. 9 Transcatheter heart valve competitive insights
  • Fig. 10 Ancillary market outlook
  • Fig. 11 Transcatheter heart valve market driver impact
  • Fig. 12 Transcatheter heart valve market restraint impact
  • Fig. 13 Porter's Analysis
  • Fig. 14 PESTLE Analysis
  • Fig. 15 Transcatheter heart valve market: Application movement analysis
  • Fig. 16 Transcatheter heart valve market: Application outlook and key takeaways
  • Fig. 17 Transcatheter aortic valve market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Transcatheter pulmonary valve market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Transcatheter mitral valve market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Transcatheter heart valve market: Technology movement analysis
  • Fig. 21 Transcatheter heart valve market: Technology outlook and key takeaways
  • Fig. 22 Balloon expanded transcatheter valve market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Self-expanded transcatheter valve market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Global transcatheter heart valve market: Regional movement analysis
  • Fig. 25 Global transcatheter heart valve market: Regional outlook and key takeaways
  • Fig. 26 North America, by country
  • Fig. 27 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. key country dynamics
  • Fig. 29 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Canada key country dynamics
  • Fig. 31 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Mexico key country dynamics
  • Fig. 33 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 UK key country dynamics
  • Fig. 36 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Germany key country dynamics
  • Fig. 38 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 France key country dynamics
  • Fig. 40 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Italy key country dynamics
  • Fig. 42 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Spain key country dynamics
  • Fig. 44 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Denmark key country dynamics
  • Fig. 46 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Sweden key country dynamics
  • Fig. 48 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Norway key country dynamics
  • Fig. 50 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 China key country dynamics
  • Fig. 53 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Japan key country dynamics
  • Fig. 55 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 India key country dynamics
  • Fig. 57 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Thailand key country dynamics
  • Fig. 59 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 South Korea key country dynamics
  • Fig. 61 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Australia key country dynamics
  • Fig. 63 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Brazil key country dynamics
  • Fig. 66 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Argentina key country dynamics
  • Fig. 68 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 South Africa key country dynamics
  • Fig. 71 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Saudi Arabia key country dynamics
  • Fig. 73 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 UAE key country dynamics
  • Fig. 75 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Kuwait key country dynamics
  • Fig. 77 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key company categorization
  • Fig. 79 Heat map analysis 2024